Organon Return On Asset vs. Shares Outstanding

OGN Stock  USD 15.98  0.19  1.20%   
Considering Organon's profitability and operating efficiency indicators, Organon's profitability may be sliding down. It has an above-average probability of reporting lower numbers next quarter. Profitability indicators assess Organon's ability to earn profits and add value for shareholders. At this time, Organon's Price To Sales Ratio is very stable compared to the past year. As of the 28th of November 2024, Price Sales Ratio is likely to grow to 0.77, while Days Sales Outstanding is likely to drop 60.09. At this time, Organon's Net Income Per E B T is very stable compared to the past year.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.480.5984
Significantly Down
Pretty Stable
Net Profit Margin0.250.1633
Way Up
Slightly volatile
Operating Profit Margin0.340.2122
Way Up
Pretty Stable
Pretax Profit Margin0.10.1075
Significantly Down
Slightly volatile
Return On Assets0.08060.0848
Notably Down
Slightly volatile
For Organon profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Organon to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Organon Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Organon's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Organon Co over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organon. If investors know Organon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
5.081
Dividend Share
1.12
Earnings Share
5.05
Revenue Per Share
24.984
Quarterly Revenue Growth
0.041
The market value of Organon is measured differently than its book value, which is the value of Organon that is recorded on the company's balance sheet. Investors also form their own opinion of Organon's value that differs from its market value or its book value, called intrinsic value, which is Organon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organon's market value can be influenced by many factors that don't directly affect Organon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Organon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Organon Shares Outstanding vs. Return On Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Organon's current stock value. Our valuation model uses many indicators to compare Organon value to that of its competitors to determine the firm's financial worth.
Organon Co is rated below average in return on asset category among its peers. It is rated below average in shares outstanding category among its peers creating about  3,255,866,094  of Shares Outstanding per Return On Asset. As of the 28th of November 2024, Common Stock Shares Outstanding is likely to grow to about 279.5 M. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Organon's earnings, one of the primary drivers of an investment's value.

Organon's Earnings Breakdown by Geography

Organon Shares Outstanding vs. Return On Asset

Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Organon

Return On Asset

 = 

Net Income

Total Assets

 = 
0.0791
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Organon

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
257.54 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

Organon Shares Outstanding Comparison

Organon is currently under evaluation in shares outstanding category among its peers.

Organon Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Organon, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Organon will eventually generate negative long term returns. The profitability progress is the general direction of Organon's change in net profit over the period of time. It can combine multiple indicators of Organon, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-541 M-568 M
Operating Income1.3 B1.9 B
Income Before Tax673 M639.4 M
Net Income Applicable To Common Shares825.3 M1.5 B
Net IncomeB1.5 B
Income Tax Expense-350 M-332.5 M
Net Income From Continuing Ops585 M555.8 M
Total Other Income Expense Net-656 M-623.2 M
Net Interest Income-517 M-491.1 M
Change To Netincome162.9 M230.8 M
Net Income Per Share 4.01  7.82 
Income Quality 0.78  1.42 
Net Income Per E B T 1.52  1.60 

Organon Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Organon. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Organon position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Organon's important profitability drivers and their relationship over time.

Use Organon in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Organon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will appreciate offsetting losses from the drop in the long position's value.

Organon Pair Trading

Organon Co Pair Trading Analysis

The ability to find closely correlated positions to Organon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Organon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Organon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Organon Co to buy it.
The correlation of Organon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organon moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Organon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Organon position

In addition to having Organon in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cigarettes Thematic Idea Now

Cigarettes
Cigarettes Theme
Tobacco makers and distributors across globe. The Cigarettes theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cigarettes Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Organon offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organon's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organon Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organon Co Stock:
Check out Your Equity Center.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
To fully project Organon's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Organon at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Organon's income statement, its balance sheet, and the statement of cash flows.
Potential Organon investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Organon investors may work on each financial statement separately, they are all related. The changes in Organon's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Organon's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.